Carboxy oxazole or thiazole compounds as DGAT-1 inhibitors useful for the treatment of obesity
申请人:Jadhav Ravindra Dnyandev
公开号:US08722901B2
公开(公告)日:2014-05-13
Heteroaryl compounds, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or disorders mediated by Diacylglycerol acyltransferase (DGAT) enzyme, particularly DGAT-1 is described.
本发明涉及杂环芳基化合物,其制备方法,包含它们的制药组合物及其在治疗由Diacylglycerol acyltransferase(DGAT)酶介导的疾病或疾病中的应用,特别是DGAT-1。